PMID: 9631366Jun 19, 1998Paper

Phase II study of paclitaxel (Taxol) and ifosfamide (Holoxan) in inoperable non-small-cell lung cancer

Lung Cancer : Journal of the International Association for the Study of Lung Cancer
S Thongprasert

Abstract

A total of 27 patients with advanced previously untreated non-small-cell lung cancer were treated with paclitaxel and ifosfamide. The starting dose of paclitaxel was 175 mg/m2 given for 3 h by intravenous infusion on day 1. Ifosfamide 4 g/m2 was given for 4 h by intravenous infusion on day 2. Dosage of the two drugs was modified according to nadir white blood count after each cycle. Involved in the treatment were 17 males and 10 female patients. The median age was 61 years (range 47-71 years) and the median Karnofsky performance status was 70% (range 60-90%), 13 cases were stage IIIb and 14 cases were stage IV. One case was not evaluable due to lost follow-up after a single dose of chemotherapy. There were five cases not determined due to a timing error. Of 21 evaluable cases, eight achieved partial response (PR 38%, confidence interval 18.1-61.5%), seven achieved stable disease, two had a minor response. The median survival time of the whole group was 255 days (range from 38 to 567 days). The major toxicities were myalgia; arthralgia and neuropathies. Throughout the study, only three cases (15%) were treated at dose level 0. After the first cycle, 18 cases were treated at dose level 1, after a second cycle, 13 cases were treat...Continue Reading

References

Mar 3, 1993·Journal of the National Cancer Institute·W K MurphyM N Raber
Dec 1, 1996·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·E R SalomaaJ Komi
Jun 9, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David S EttingerUNKNOWN Radiation Therapy Oncology Group 9609

❮ Previous
Next ❯

Citations

Nov 1, 1990·British Journal of Clinical Pharmacology·L D LewisH J Rogers
Jul 5, 2005·Expert Opinion on Investigational Drugs·M Ranson, N Thatcher
Jul 13, 2007·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Sarah ParkKeunchil Park
Jan 17, 2014·Journal of Psychosocial Oncology·Cati G Brown JohnsonJanine K Cataldo
Jul 3, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nobuyuki KatakamiNobuyuki Yamamoto
Dec 11, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Leena GandhiJean-Charles Soria
Apr 22, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Scott N GettingerJulie R Brahmer
Dec 25, 2008·Pharmaceutical Research·Christine Vauthier, Kawthar Bouchemal
Nov 6, 2012·Animal : an International Journal of Animal Bioscience·M HerreroM C Rufino
Nov 3, 2016·Nature Reviews. Clinical Oncology·Pavan P AdiseshaiahScott E McNeil
Aug 11, 2018·Scientific Reports·A BlednykhL Wiegart
Sep 20, 2019·Singapore Medical Journal·Benjamin Rui Sheng SiowChong Jin Yeo
May 27, 2014·American Society of Clinical Oncology Educational Book·Heather WakeleeMartin J Edelman
May 27, 2014·American Society of Clinical Oncology Educational Book·Mark G KrisJamie E Chaft
Nov 18, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christopher G AzzoliUNKNOWN American Society of Clinical Oncology
Nov 7, 2019·Neurorehabilitation and Neural Repair·Hui ZhongV Reggie Edgerton
Jan 25, 2003·The Journal of Pharmacy and Pharmacology·Kevin J HarringtonRichard G Vile

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of the National Cancer Institute
Nancy J Nelson
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
W K EvansS Dahrouge
Lung Cancer : Journal of the International Association for the Study of Lung Cancer
Mark A SocinskiDavid Garfield
Annals of Oncology : Official Journal of the European Society for Medical Oncology
P C HoffmanEverett E Vokes
© 2022 Meta ULC. All rights reserved